Attached files

file filename
10-K - FORM 10-K - ARROWHEAD PHARMACEUTICALS, INC.d10k.htm
EX-4.7 - FORM OF WARRANT TO PURCHASE CAPITAL STOCK - ARROWHEAD PHARMACEUTICALS, INC.dex47.htm
EX-4.2 - FORM OF REGISTRATION RIGHTS AGREEMENT - ARROWHEAD PHARMACEUTICALS, INC.dex42.htm
EX-3.4 - CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION - ARROWHEAD PHARMACEUTICALS, INC.dex34.htm
EX-21.1 - LIST OF SUBSIDIARIES - ARROWHEAD PHARMACEUTICALS, INC.dex211.htm
EX-32.1 - SECTION 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER - ARROWHEAD PHARMACEUTICALS, INC.dex321.htm
EX-10.8 - AMENDMENT TO EMPLOYMENT AGREEMENT - ARROWHEAD PHARMACEUTICALS, INC.dex108.htm
EX-23.1 - CONSENT OF INDEPENDENT PUBLIC REGISTERED ACCOUNTING FIRM - ARROWHEAD PHARMACEUTICALS, INC.dex231.htm
EX-31.1 - SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER - ARROWHEAD PHARMACEUTICALS, INC.dex311.htm
EX-31.2 - SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER - ARROWHEAD PHARMACEUTICALS, INC.dex312.htm
EX-32.2 - SECTION 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER - ARROWHEAD PHARMACEUTICALS, INC.dex322.htm
EX-10.22 - FORM OF SUBSCRIPTION AGREEMENT, DATED AS OF SEPTEMBER 30, 2009 - ARROWHEAD PHARMACEUTICALS, INC.dex1022.htm
EX-10.23 - SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT - ARROWHEAD PHARMACEUTICALS, INC.dex1023.htm
EX-10.24 - FORM OF SUBSCRIPTION AGREEMENT DATED DECEMBER 11, 2009 - ARROWHEAD PHARMACEUTICALS, INC.dex1024.htm

Exhibit 10.6

AMENDMENT TO SEVERANCE AGREEMENT

This Amendment (“Amendment”) to the Severance Agreement dated May 24, 2007 (“Agreement”) between R. Bruce Stewart (“Executive”) and Arrowhead Research Corporation (“Company”), a Delaware corporation located at 201 S. Lake Avenue, Suite 703, Pasadena, CA 91101, is made and entered into as May 12, 2009 (“Effective Date”).

WHEREAS, the Company and the Executive seek to amend the Agreement;

NOW THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, such parties intending to be legally bound, agree as follows:

Section 3 of the Agreement shall be discharged and rendered moot in its entirety; and shall be replaced with the following Section 3:

3. Retirement or Termination of Employment

The following shall govern Executive’s retirement or termination (except in the case of Section 5 below): Should Executive voluntarily retire or voluntarily terminate from Arrowhead Research Corporation or its successor for any reason or should Executive be terminated from Arrowhead Research Corporation or its successor for any reason, Executive will be paid a single lump sum amount equivalent to one (1) month of his highest monthly salary while at Arrowhead Research Corporation.

IN WITNESSETH WHEREOF, each of the parties has duly executed the Amendment effective as of the Effective Date.

 

Dated: May 12, 2009

    ARROWHEAD RESEARCH CORPORATION
   

/s/ Paul C. McDonnel

    Paul C. McDonnel
    Chief Financial Officer

Dated: May 12, 2009

    EXECUTIVE
   

/s/ R. Bruce Stewart

    R. Bruce Stewart
    Executive Chairman